Patent · US Active

Macrocyclic indole derivatives useful as hepatitis C virus inhibitors

US9427440B2 · kind B2 · utility

2Cited by

5References

13Claims

0Family size

Assignee

Janssen Sciences Ireland UC · IE

Inventors

Sandrine Marie Helene Vendeville · Woluwe-Saint-Pierre - Sint-Pieters-Woluwe, BE
Pierre Jean-Marie Bernard Raboisson · Sligo, IE
Tse-I Lin · Mechelen, BE
Abdellah Tahri · Anderlecht, BE
Katie Ingrid Eduard Amssoms · Hove, BE

Key dates

Filing date	Mar 15, 2013
Grant date	Aug 30, 2016
Priority date	—
Expiry date	Mar 15, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D515/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Inhibitors of HCV replication of formula (I)including stereochemically isomeric forms, and salts, hydrates, solvates thereof, wherein R1, R2, R4, R5, R6 and R7 have the meaning defined in the claims.The present invention also relates to processes for preparing said compounds, pharmaceutical compositions containing them and their use in HCV therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.